Dynamics in Post-pandemic Global Etoricoxib Intermediate Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ662220 No. of Pages: 138 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Etoricoxib Intermediate market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Etoricoxib Intermediate market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category 0.98 0.99 Segmented by End User/Segment Rheumatoid Arthritis Psoriatic Arthritis Osteoarthritis Ankylosing Spondylitis Chronic Low Back Pain Acute Pain Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Sun Pharmaceutical Pfizer Perrigo Novacap Merck Kopran GlaxoSmithKline Geri-Care Bayer Abbott
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Etoricoxib Intermediate Market Status and Forecast (2016-2027)
1.3.2 Global Etoricoxib Intermediate Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Etoricoxib Intermediate Supply by Company
2.1 Global Etoricoxib Intermediate Sales Volume by Company
2.2 Global Etoricoxib Intermediate Sales Value by Company
2.3 Global Etoricoxib Intermediate Price by Company
2.4 Etoricoxib Intermediate Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Etoricoxib Intermediate Market Status by Category
3.1 Etoricoxib Intermediate Category Introduction
3.1.1 0.98
3.1.2 0.99
3.2 Global Etoricoxib Intermediate Market by Category
3.2.1 Global Etoricoxib Intermediate Sales Volume by Category (2016-2021)
3.2.2 Global Etoricoxib Intermediate Sales Value by Category (2016-2021)
3.2.3 Global Etoricoxib Intermediate Price by Category (2016-2021)
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Etoricoxib Intermediate Market Status by End User/Segment
4.1 Etoricoxib Intermediate Segment by End User/Segment
4.1.1 Rheumatoid Arthritis
4.1.2 Psoriatic Arthritis
4.1.3 Osteoarthritis
4.1.4 Ankylosing Spondylitis
4.1.5 Chronic Low Back Pain
4.1.6 Acute Pain
4.1.7 Others
4.2 Global Etoricoxib Intermediate Market by End User/Segment
4.2.1 Global Etoricoxib Intermediate Sales Volume by End User/Segment (2016-2021)
4.2.2 Global Etoricoxib Intermediate Sales Value by End User/Segment (2016-2021)
4.2.3 Global Etoricoxib Intermediate Price by End User/Segment (2016-2021)
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Etoricoxib Intermediate Market Status by Region
5.1 Global Etoricoxib Intermediate Market by Region
5.1.1 Global Etoricoxib Intermediate Sales Volume by Region
5.1.2 Global Etoricoxib Intermediate Sales Value by Region
5.2 North America Etoricoxib Intermediate Market Status
5.3 Europe Etoricoxib Intermediate Market Status
5.4 Asia Pacific Etoricoxib Intermediate Market Status
5.5 Central & South America Etoricoxib Intermediate Market Status
5.6 Middle East & Africa Etoricoxib Intermediate Market Status
6 North America Etoricoxib Intermediate Market Status
6.1 North America Etoricoxib Intermediate Market by Country
6.1.1 North America Etoricoxib Intermediate Sales Volume by Country (2016-2021)
6.1.2 North America Etoricoxib Intermediate Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Etoricoxib Intermediate Market Status
7.1 Europe Etoricoxib Intermediate Market by Country
7.1.1 Europe Etoricoxib Intermediate Sales Volume by Country (2016-2021)
7.1.2 Europe Etoricoxib Intermediate Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Etoricoxib Intermediate Market Status
8.1 Asia Pacific Etoricoxib Intermediate Market by Country
8.1.1 Asia Pacific Etoricoxib Intermediate Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Etoricoxib Intermediate Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Etoricoxib Intermediate Market Status
9.1 Central & South America Etoricoxib Intermediate Market by Country
9.1.1 Central & South America Etoricoxib Intermediate Sales Volume by Country (2016-2021)
9.1.2 Central & South America Etoricoxib Intermediate Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Etoricoxib Intermediate Market Status
10.1 Middle East & Africa Etoricoxib Intermediate Market by Country
10.1.1 Middle East & Africa Etoricoxib Intermediate Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Etoricoxib Intermediate Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Etoricoxib Intermediate Manufacturing Cost Analysis
11.5 Etoricoxib Intermediate Sales Channel and Distributors Analysis
11.5.1 Etoricoxib Intermediate Sales Channel
11.5.2 Etoricoxib Intermediate Distributors
11.6 Etoricoxib Intermediate Downstream Major Buyers
12 Global Etoricoxib Intermediate Market Forecast by Category and by End User/Segment
12.1 Global Etoricoxib Intermediate Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Etoricoxib Intermediate Forecast by Category
12.2.1 Global Etoricoxib Intermediate Sales Volume Forecast by Category
12.2.2 Global Etoricoxib Intermediate Sales Value Forecast by Category
12.2.3 Global Etoricoxib Intermediate Price Forecast by Category
12.3 Global Etoricoxib Intermediate Forecast by End User/Segment
12.3.1 Global Etoricoxib Intermediate Sales Volume Forecast by End User/Segment
12.3.2 Global Etoricoxib Intermediate Sales Value Forecast by End User/Segment
12.3.3 Global Etoricoxib Intermediate Price Forecast by End User/Segment
13 Global Etoricoxib Intermediate Market Forecast by Region/Country
13.1 Global Etoricoxib Intermediate Market Forecast by Region (2022-2027)
13.1.1 Global Etoricoxib Intermediate Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Etoricoxib Intermediate Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Sun Pharmaceutical
14.1.1 Company Information
14.1.2 Etoricoxib Intermediate Product Introduction
14.1.3 Sun Pharmaceutical
Etoricoxib Intermediate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Pfizer
14.2.1 Company Information
14.2.2 Etoricoxib Intermediate Product Introduction
14.2.3 Pfizer
Etoricoxib Intermediate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Perrigo
14.3.1 Company Information
14.3.2 Etoricoxib Intermediate Product Introduction
14.3.3 Perrigo
Etoricoxib Intermediate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Novacap
14.4.1 Company Information
14.4.2 Etoricoxib Intermediate Product Introduction
14.4.3 Novacap
Etoricoxib Intermediate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Merck
14.5.1 Company Information
14.5.2 Etoricoxib Intermediate Product Introduction
14.5.3 Merck
Etoricoxib Intermediate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Kopran
14.6.1 Company Information
14.6.2 Etoricoxib Intermediate Product Introduction
14.6.3 Kopran
Etoricoxib Intermediate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 GlaxoSmithKline
14.7.1 Company Information
14.7.2 Etoricoxib Intermediate Product Introduction
14.7.3 GlaxoSmithKline
Etoricoxib Intermediate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Geri-Care
14.8.1 Company Information
14.8.2 Etoricoxib Intermediate Product Introduction
14.8.3 Geri-Care
Etoricoxib Intermediate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 Bayer
14.9.1 Company Information
14.9.2 Etoricoxib Intermediate Product Introduction
14.9.3 Bayer
Etoricoxib Intermediate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 Abbott
14.10.1 Company Information
14.10.2 Etoricoxib Intermediate Product Introduction
14.10.3 Abbott
Etoricoxib Intermediate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
15 Conclusion
16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com